Sacituzumab Tirumotecan Plus Anlotinib in Previously Treated ES-SCLC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sacituzumab Tirumotecan Plus Anlotinib in Previously Treated ES-SCLC	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Not yet recruiting	Phase 2	2026-02-05		NCT07388875

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
China Medical University, China	25

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials